How big is the Companion Diagnostics Market?

The Companion Diagnostics Market size is expected to reach USD 7.74 billion in 2024 and grow at a CAGR of 12.42% to reach USD 13.90 billion by 2029. Read More

What is the current Companion Diagnostics Market size?

In 2024, the Companion Diagnostics Market size is expected to reach USD 7.74 billion. Read More

Who are the key players in Companion Diagnostics Market?

Qiagen NV, Agilent Technologies Inc., Abbott, Biomerieux and F. Hoffmann-La Roche Ltd are the major companies operating in the Companion Diagnostics Market. Read More

Which is the fastest growing region in Companion Diagnostics Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Companion Diagnostics Market?

In 2024, the North America accounts for the largest market share in Companion Diagnostics Market. Read More

What years does this Companion Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Companion Diagnostics Market size was estimated at USD 6.78 billion. The report covers the Companion Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Companion Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the future growth prospects for the Companion Diagnostics Market?

The future growth prospects for the Companion Diagnostics Market are a) Growing awareness and acceptance by healthcare professionals b) Demand for companion diagnostics to identify patients who will benefit from specific cancer treatments Read More

What are the future growth prospects for the Companion Diagnostics Market?

The future growth prospects for the Companion Diagnostics Market are a) Growing awareness and acceptance by healthcare professionals b) Demand for companion diagnostics to identify patients who will benefit from specific cancer treatments Read More

Companion Diagnostics Market Share

Statistics for the 2023 & 2024 Companion Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Companion Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Companion Diagnostics Industry

The companion diagnostics market is highly fragmented and competitive, with several major players. The rising focus of companies on personalized medicine, co-development activities, and increased cases of adverse drug reactions are expected to boost the market's competitive nature. Some of the key players in the market are Abbott, Agilent Technologies Inc., F Hoffmann-La Roche Ltd, Biomerieux, Qiagen NV, and Siemens Healthineers AG.